SCPS's logo.
Ticker Symbol: SCPS

Scopus Biopharma Inc

$3.54 - 20-11-2024 4 p.m. ET

Exchange: OTC MARKETS Currency: USD Asset Type: Common Stock CIK:0001772028

Company Profile

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company’s lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. This drug candidate is highly distinctive, encompassing both gene therapy and immunotherapy by synthetically linking siRNA to an oligonucleotide TLR9 agonist, creating the potential for targeted gene silencing with simultaneous TLR stimulation and immune activation in the tumor microenvironment. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: December 16, 2022 04:00 PM EST
Previous Close: $0.16
Change: -$0.17 ( -50.54%)
Days Range: $0.04 - $0.16
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change -50.54%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 42084264

Valuation

Market Cap: 707.9M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A